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Background-—Guidelines recommend exercise for cardiovascular health, although evidence from trials linking exercise to
cardiovascular health through intermediate biomarkers remains inconsistent. We performed a meta-analysis of randomized
controlled trials to quantify the impact of exercise on cardiorespiratory ﬁtness and a variety of conventional and novel
cardiometabolic biomarkers in adults without cardiovascular disease.
Methods and Results-—Two researchers selected 160 randomized controlled trials (7487 participants) based on literature
searches of Medline, Embase, and Cochrane Central (January 1965 to March 2014). Data were extracted using a standardized
protocol. A random-effects meta-analysis and systematic review was conducted to evaluate the effects of exercise interventions on
cardiorespiratory ﬁtness and circulating biomarkers. Exercise signiﬁcantly raised absolute and relative cardiorespiratory ﬁtness.
Lipid proﬁles were improved in exercise groups, with lower levels of triglycerides and higher levels of high-density lipoprotein
cholesterol and apolipoprotein A1. Lower levels of fasting insulin, homeostatic model assessment–insulin resistance, and
glycosylated hemoglobin A1c were found in exercise groups. Compared with controls, exercise groups had higher levels of
interleukin-18 and lower levels of leptin, ﬁbrinogen, and angiotensin II. In addition, we found that the exercise effects were modiﬁed
by age, sex, and health status such that people aged <50 years, men, and people with type 2 diabetes, hypertension, dyslipidemia,
or metabolic syndrome appeared to beneﬁt more.
Conclusions-—This meta-analysis showed that exercise signiﬁcantly improved cardiorespiratory ﬁtness and some cardiometabolic
biomarkers. The effects of exercise were modiﬁed by age, sex, and health status. Findings from this study have signiﬁcant
implications for future design of targeted lifestyle interventions. ( J Am Heart Assoc. 2015;4:e002014 doi: 10.1161/
JAHA.115.002014)
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C ardiovascular disease (CVD) remains a leading cause ofmorbidity and mortality affecting 84 million people in
the United States.1–3 Current guidelines recommend exercise
for both primary and secondary prevention of CVD.4–6 Obser-
vational studies have associated exercise with lower CVD risk
in populations free of preexisting CVD.7–9 Substantial evidence
from secondary prevention studies also conﬁrms better
survival and reduced CVD recurrence after exercise interven-
tions.10,11 Because of apparent ethical and feasibility issues,
however, no long-term randomized controlled trials (RCTs) have
directly investigated the beneﬁts and risks of exercise train-
ing in relation to CVD incidence.12 Consequently, exercise
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ORIGINAL RESEARCH
interventions among healthy populations have focused on
intermediate CVD biomarkers. Changes in circulating CVD
biomarkers and cardiorespiratory ﬁtness (CRF) are reasonable
indicators for the favorable effects of exercise training on
cardiovascular health.
An important component of health-related ﬁtness, CRF
refers to the capacity of respiratory and cardiovascular
systems to provide muscles with oxygen during sustained
and/or intense exercise. Available evidence has shown that
CRF can signiﬁcantly improve the predictive ability of both
short- and long-term CVD risk when added to traditional risk
factors.13 In addition to serving as a diagnostic and prognostic
health indicator in clinical settings, CRF has been used as an
indicator of habitual exercise.14,15
Traditional CVD biomarkers, such as non–high-density
lipoprotein cholesterol and high-sensitivity C-reactive protein,
may also have the potential to be used in CVD risk
prediction.16–19 Although most previous studies examining
the relationship between exercise and circulating biomarkers
focus on commonly measured CVD biomarkers, an increasing
number of studies are evaluating novel biomarkers.20,21
Evidence has implicated, for example, relevant biomarkers
in insulin resistance and inﬂammation that contribute to CVD
development.22–26
Nevertheless, much remains uncertain concerning the
effects of exercise on both traditional and novel CVD
biomarkers for targeted interventions and clinical evalua-
tions.20,21,27 The primary objective of this meta-analysis was
to assess the effects of exercise training on CRF and a variety
of both traditional and novel circulating CVD biomarkers.
Furthermore, we aimed to investigate the sources of heter-
ogeneity, especially by potential effect modiﬁers such as age,
sex, obesity, lifestyle, preexisting conditions (type 2 diabetes,
hypertension, hyperlipidemia, or metabolic syndrome), and
intervention duration and intensity.
Methods
Data Sources and Searches
We developed and followed a standardized protocol to do this
meta-analysis in accordancewith the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA) guide-
lines.28 Two investigators (X.L., X.Z.) independently conducted
literature searches of Medline, Embase, and the Cochrane
Central Register of Controlled Trials published from January
1965 (index date) to March 2014, using keywords and Medical
Subject Headings (Table 1). All relevant studies and review
articles (including meta-analysis) and the reference lists of the
identiﬁed articles were checked manually. Any disagreements
between 2 investigators were resolved by consensus. Institu-
tional review board approval is not applicable because the
current study is a systematic review andmeta-analysis, which is
not considered research involving human subjects.
Study Selection
Articles were included (1) if the study was an RCT that
assigned at least 1 group of participants to exercise training
and 1 group to control and (2) if CRF (absolute and relative
maximal oxygen uptake) or circulating CVD biomarkers of lipid
and lipoprotein metabolism, glucose intolerance and insulin
resistance, systemic inﬂammation, or hemostasis were mea-
sured at baseline and at the end of the trial.
All abstracts about RCTs reporting the effect of exercise
training on CVD-related biomarkers or CRF were included for
screening. We excluded studies (1) if the study design was not
a RCT; (2) if the exercise intervention was acute (≤1 week),
because we are interested in the effects of exercise
interventions of moderate to long duration; (3) if interventions
were based on education or counseling rather than a
structured exercise training assignment; (4) if maximal oxygen
consumption, or VO2max, was indirectly calculated through
heart rate or ﬁxed time testing and no other biomarkers of
interest to this study were reported; (5) if levels of circulating
biomarkers were not directly measured; (6) if values of
outcome measures at the end of trials were not reported; (7) if
participants had severe chronic diseases (preexisting CVD,




4. or/1 to 3
5. exp Biological Markers/
6. Exercise Tolerance/
7. Exercise Test/
8. exp Oxygen Consumption/
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liver or kidney diseases, or cancers), any other conditions that
could potentially compromise participants’ capacity to exer-
cise (disability, frailty, declined activities of daily living, or
wheelchair dependency), or any mental conditions (depres-
sion, anxiety, schizophrenia, bipolar disorder, Parkinson’s
disease, or Alzheimer’s disease); (8) if participants were
identiﬁed as trained professionals, athletes, or soldiers; (9) if
participants were infants, children, or adolescents; or (10) if
participants were pregnant, postpartum, nursing, had recent
surgery, or were undergoing rehabilitation exercise. If multiple
articles were published based on the same trial, data were
retrieved as 1 independent trial. If there were duplicate results
from the same trial, the most updated and comprehensive
ones were extracted.
Data Extraction and Quality Assessment
In total, 6135 articles were retrieved from the literature
search. We excluded 5796 articles after abstract review and
170 after full-text examination. Data extraction was con-
ducted independently by 2 investigators (X.L., X.Z.), and
discrepancies were resolved through consensus. The follow-
ing information was extracted from all eligible studies: general
information (ﬁrst author’s name, article title, and country of
origin), study characteristics (study design, eligibility criteria,
randomization, blinding, cointervention, dropout rate, and
reason for dropping out), participant characteristics (age, sex,
ethnicity, body mass index, life style, health status, and
number of participants in each group), intervention and
setting (exercise type, duration, intensity, and supervision),
and outcome measures (deﬁnition of outcomes, statistical
techniques, pre- and postintervention means, standard devi-
ation, sample size of each arm, and adverse events). Maximal
oxygen uptake VO2max was measured directly and determined
based on the highest VO2 obtained prior to volitional fatigue.
In this meta-analysis, we focused on biomarkers in blood
samples, including plasma, serum, and whole blood. All
samples for fasting glucose and insulin measurement in the
studies were collected after >10 hours of fasting.
Data Synthesis and Analysis
Methodological quality was assessed by 2 investigators (X.L.,
X.Z.) using the Cochrane Collaboration’s tool for assessing
risk of bias.29 This included random sequence generation,
allocation concealment, blinding of participants and person-
nel, blinding of outcome assessment, incomplete outcome
data, selective reporting, and other sources of bias. For each
trial, the risk of bias was reported as low risk, unclear risk, or
high risk. Disagreement was resolved by discussion. All
eligible comparisons from each trial were extracted separately
according to exercise intensity. The criteria for classifying
exercise interventions as moderate exercise or vigorous
exercise are summarized in Table 2. If the intensity measures
were not reported in individual studies, maximum heart rate,
maximum heart rate percentage, speed of running, metabolic
equivalent, oxygen uptake, or relative metabolic rate were
used to classify exercise intensity. To maintain independence,
the most vigorous intervention and the control group in each
trial were included in the primary analysis if multiple training
groups of different intensities were compared with a single
control group. Sensitivity analyses were performed by
conducting separate analyses of all eligible comparisons for
moderate and vigorous exercise interventions, respectively.
Mean levels and standard deviations of CRF and CVD
biomarkers after the exercise interventions from individual
trials were used to calculate weighted mean differences
(WMDs) and 95% CIs using DerSimonian and Laird random-
effects models.30 Between-study heterogeneity was examined
using Q statistics and I2 statistics.31,32 I225%, 50%, and 75% is
suggestive, respectively, of low, medium, and high heterogene-
ity. Egger’s tests were used to formally test publication bias.33 If
there was any evidence of publication bias, the trim and ﬁll
method was used to evaluate the impact of publication bias.34
All eligible trials were analyzed in subgroup analyses
conducted within the strata of the predetermined potential
modiﬁers, including age (mean or median <50 versus
≥50 years), sex (women versus men), body mass index (obese
versus nonobese), lifestyle (active versus sedentary), health
status (having at least 1 of the following comorbidities: type 2
diabetes, hypertension, hyperlipidemia, and metabolic syn-
drome versus none), and trial duration (≥16 versus
<16 weeks). Obesity was deﬁned as body mass index ≥30
kg/m2. Active lifestyle was deﬁned according to the report of
individual trials. Health status was conﬁrmed by clinical
diagnosis or reported medication use. Metaregressions were
performed to evaluate the overall impact of potential modiﬁers.
Two-sided P≤0.05 was used as the signiﬁcance level
except for the Q statistic and the Egger’s tests (P=0.10).35 All
statistical analyses were performed with Stata statistical
software version 12 (Stata Corp).
Table 2. Criteria Used for Exercise Intensity Classiﬁcation
Moderate Vigorous
Maximum heart rate, beats/min <140 ≥140
Maximum heart rate, % <75 ≥75
Speed of running, m/s <6.8 ≥6.8
Metabolic equivalents Women: <6 Women: ≥6
Men: <8 Men: ≥8
Oxygen uptake (% of VO2max) <70 ≥70
Relative metabolic rate <8 ≥8
DOI: 10.1161/JAHA.115.002014 Journal of the American Heart Association 3
















Figure 1 shows the number of trials included in the
analysis for each outcome. A total of 7487 participants aged
between 18 and 90 years, from 169 articles based on 160
RCTs, were included in the meta-analysis. Characteristics of
eligible studies are summarized in Table 3. Among all partic-
ipants, 4276 (57.1%) were women; 3211 (42.9%) were men;
5845 (78.1%) were free of type 2 diabetes, hypertension,
hyperlipidemia, or metabolic syndrome; and 1640 (21.9%) had
at least 1 of those conditions. The median duration of trials
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Figure 1. Summary of study selection process. In total, 6135 articles were retrieved from the literature
search that evaluated the effect of exercise interventions on CRF or cardiometabolic biomarkers. We
excluded 5796 articles after abstract review and 170 after full text examination. After exclusion, 160 RCTs
reported in 169 articles were included in the meta-analysis. Apo AI indicates apolipoprotein A1; Apo AII,
apolipoprotein A2; Apo B, apolipoprotein B; CRF, cardiorespiratory ﬁtness; CRP, C-reactive protein; FFA, free
fatty acid; HbA1c, glycosylated hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; HOME-B,
homeostatic model assessment-beta cell function; HOMA-IR, homeostatic model assessment–insulin
resistance; HOMA-S, homeostatic model assessment-insulin sensitivity; ICAM-1, intercellular adhesion
molecule 1; IGF-1, insulin-like growth factor 1; IGF-BP, insulin-like growth factor binding protein; IL,
interleukin; LDL-C, low-density lipoprotein cholesterol; Lp(a), lipoprotein(a); PAI-1, plasminogen activator
inhibitor-1; RCTs, randomized controlled trials; TC, total cholesterol; TG, triglycerides; TNF-a, tumor necrosis
factor a; VCAM-1, vascular cell adhesion molecule 1; VLDL-C, very low-density lipoprotein cholesterol.
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Description of Study Quality
The quality of studies included was heterogeneous (Figure 2).
Random sequence generation was reported in 50 trials, and
allocation concealment was reported in 20 trials; only 1 of
these trials showed a high probability of selection bias
because the random allocation was not concealed. The risk of
potential performance bias was high in all trials because it
was not possible to blind participants and trainers in exercise
interventions. Among 26 trials reporting the blinding of
outcome assessment, the risk of detection bias was high in
only 1 trial. The risk of other bias was high in 46 trials
because of poor compliance, the use of intention-to-treat
analysis, limited sample sizes, or limitations discussed in
individual articles.
Cardiorespiratory Fitness
A total of 67 and 123 independent comparisons were
included in the primary analysis for absolute and relative
CRF, respectively (Table 4). Both measures were signiﬁcantly
raised by exercise interventions (both P<0.001). The WMDs
comparing exercise groups and control groups were 0.28 L/
min (95% CI 0.23 to 0.33; I2=93.7%; P<0.001 for heteroge-
neity) for absolute CRF and 3.90 mL/kg per minute (95% CI
3.45 to 4.35; I2=91.4%; P<0.001 for heterogeneity) for
relative CRF. The Egger’s tests showed evidence of publica-
tion bias in both instances (P<0.05). When applying the trim
and ﬁll method, the conclusion regarding the associations
between exercise training and CRF did not change (ﬁlled
analysis for absolute CRF: WMD 0.14 L/min, 95% CI 0.20
to 5.28, P<0.001; ﬁlled analysis for relative CRF: WMD
2.56 mL/kg per minute, 95% CI 3.06 to 10.16, P<0.001).
Lipid and Lipoprotein Markers
The number of comparisons for each lipid and lipoprotein
marker is shown in Table 4. Exercise training signiﬁcantly
lowered the levels of triglycerides (P=0.02) and increased the
levels of high-density lipoprotein cholesterol (HDL-C; P<0.001)
and apolipoprotein A1 (P<0.001). The WMDs were5.31 mg/
dL (95% CI 10.63 to 0.89; I2=71.8%; P<0.001 for hetero-
geneity) for triglycerides, 2.32 mg/dL (95% CI 1.16 to 3.87;
I2=87.5%; P<0.001 for heterogeneity) for HDL-C, and 0.03 g/L
(95% CI 0.02 to 0.04; I2=0.0%; P=0.81 for heterogeneity) for
apolipoprotein A1. The P value of the Egger’s test for HDL-Cwas
0.03, suggesting possible publication bias; however, the results
from the trim and ﬁll analysis did not show substantial impact of
publication bias on the estimates or the statistics (ﬁlled
analysis: WMD 2.32 mg/dL, 95% CI 1.16 to 3.87, P<0.001).
Adipokine and Inﬂammatory Markers
Signiﬁcant associations were found for interleukin-18 (WMD
18.3 pg/mL; 95% CI 0.10 to 36.6; I2=0.0%; P=0.95 for
heterogeneity) but not for C-reactive protein, interleukin-6, or
tumor necrosis factor a in the primary analysis (Table 4).
Although there was no effect on adiponectin, exercise training
was signiﬁcantly associated with reduced levels of leptin
(WMD 2.72 ng/mL; 95% CI 4.03 to 1.42; I2=82.10%;
P<0.001 for heterogeneity) (Table 4).
Markers of Glucose Intolerance and Insulin
Resistance
Table 4 also shows the effects of exercise training on markers
of glucose intolerance and insulin resistance. Fasting insulin
Figure 2. Assessment of risk of bias: summary for items of bias.
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levels; homeostatic model assessment–insulin resistance,
or HOMA-IR; and glycosylated hemoglobin A1c were signiﬁ-
cantly lowered in exercise groups compared with control
groups (P=0.002, P=0.002, and P<0.001) (Table 4). The
WMDs between exercise groups and control groups were
1.03 lIU/mL (95% CI 1.69 to 0.37; I2=79.8%; P<0.001




WMD 95% CI PWMDExercise Control
Cardiorespiratory fitness
Absolute, L/min 67 1448 1272 0.28 0.23 to 0.33 <0.001
Relative, mL/kg per minute 122 2543 2249 3.94 3.48 to 4.39 <0.001
Lipid and lipoprotein markers
TC, mg/dL 68 1754 1604 1.16 9.28 to 11.99 0.82
TG, mg/dL 66 1851 1703 5.31 10.63 to 0.89 0.02
HDL-C, mg/dL 74 1967 1800 2.32 1.16 to 3.87 <0.001
HDL2-C, mg/dL 5 91 92 0.39 1.93 to 2.32 0.8
HDL3-C, mg/dL 3 62 62 0.08 1.55 to 1.55 0.94
LDL-C, mg/dL 59 1681 1525 3.87 8.12 to 0.39 0.08
VLDL-C, mg/dL 7 130 102 3.09 8.51 to 2.32 0.29
Apo AI, g/L 5 63 62 0.03 0.02 to 0.04 <0.001
Apo AII, g/L 2 140 126 0.01 0.01 to 0.03 0.2
Apo B, g/L 5 103 87 0.01 0.01 to 0.03 0.4
FFA, mmol/L 6 70 62 0.06 0.14 to 0.03 0.21
Adipokine and inflammatory markers
CRP, mg/L 13 598 554 0.22 0.78 to 0.34 0.44
IL-6, pg/mL 6 130 121 0.05 0.27 to 0.17 0.66
IL-18, pg/mL 2 67 56 18.3 0.10 to 36.6 0.05
TNF-a, pg/mL 3 43 44 0.21 0.37 to 0.79 0.48
Adiponectin, lg/mL 6 273 267 0.52 0.20 to 1.23 0.16
Leptin, ng/mL 7 312 315 2.72 4.03 to 1.42 <0.001
Glucose/insulin metabolism markers
Glucose, mmol/L 49 1720 1569 0.07 0.13 to 0.004 0.06
Insulin, lIU/mL 29 1272 1149 1.03 1.69 to 0.37 0.002
HOMA-IR 14 1033 912 0.3 0.49 to 0.11 0.002
HbA1c, % 19 972 878 0.28 0.42 to 0.14 <0.001
C-peptide, nmol/L 2 66 34 0.08 0.29 to 0.46 0.67
IGF-1, ng/mL 5 230 207 3.16 2.98 to 9.31 0.31
IGF-BP3, lg/mL 2 170 164 0.002 0.23 to 0.23 0.99
Hemostatic factors
Fibrinogen, g/L 2 36 39 0.39 0.75 to 0.03 0.04
Endothelin-1, pg/mL 2 34 32 0.22 0.62 to 0.19 0.29
Angiotensin II, pg/mL 2 24 25 1.32 2.11 to 0.54 0.001
Apo AI indicates apolipoprotein A1; Apo AII, apolipoprotein A2; Apo B, apolipoprotein B; CRP, C-reactive protein; FFA, free fatty acid; HbA1c, glycosylated hemoglobin A1c; HDL-C, high-
density lipoprotein cholesterol; HOMA-IR, homeostatic model assessment–insulin resistance; IGF-1, insulin-like growth factor 1; IGF-BP3, insulin-like growth factor binding protein 3; IL,
interleukin; LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol; TG, triglycerides; TNF-a, tumor necrosis factor a; VLDL-C, very low-density lipoprotein cholesterol; WMDs,
weighted mean differences.
*Number of eligible independent comparisons.
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for heterogeneity) for fasting insulin. The WMD for HOMA-IR
was 0.30 (95% CI 0.49 to 0.11; I2=77.5%; P<0.001 for
heterogeneity), whereas the WMD for hemoglobin A1c was
0.28% (95% CI 0.42 to 0.14; I2=80.1%; P<0.001 for
heterogeneity). The Egger’s tests for fasting glucose and insulin
were not suggestive of substantial publication bias (P=0.18 and
P=0.24, respectively). The results from the trim and ﬁll analysis
suggested that there was no substantial impact of publication
bias on the results for HOMA-IR or hemoglobin A1c (ﬁlled
analysis for HOMA-IR: WMD 0.30, 95% CI 0.49 to 0.11,
P=0.002; ﬁlled analysis for hemoglobin A1c: WMD 0.28%,
95% CI 0.42 to 0.14, P<0.001).
Hemostatic Factors
The primary analysis examined 3 hemostatic factors: ﬁbrin-
ogen, endothelin-1, and angiotensin II (Table 4). On average,
the levels of ﬁbrinogen and angiotensin II were 0.39 g/L (95%
CI 0.03 to 0.75; I2=45.00%; P=0.18 for heterogeneity) and
1.32 pg/mL (95% CI 0.54 to 2.11; I2=0.00%; P=0.71 for
heterogeneity) lower in exercise groups than in control
groups. No signiﬁcant association was found for endothelin-1.
Subgroup Analyses
Our metaregression results suggest that the differences in
CRF between exercise and control groups were modiﬁed by
age and sex (absolute CRF: P=0.008 and P<0.001 for age and
sex, respectively; relative CRF: P=0.003 and P=0.001 for age
and sex, respectively) (Table 5, Figure 3). In addition, the
effects of exercise on levels of total cholesterol (P=0.04), low-
density lipoprotein cholesterol (LDL-C; P=0.06), and fasting
insulin (P=0.05) were modiﬁed by the presence of at least 1 of
the following comorbidities: type 2 diabetes, hypertension,
hyperlipidemia, and metabolic syndrome (Tables 6 and 7,
Figure 3). Sex differences in the effects of exercise were also
found for fasting insulin (P=0.04).
After conducting metaregressions, analyses within sub-
groups were performed. Compared with older people, those
aged <50 years appeared to have larger changes in CRF.
Consistent with the metaregression results, men seemed to
have greater exercise-related improvement in CRF, LDL-C, and
fasting insulin than women did (Figure 3). Exercise interven-
tions appreciably improved the levels of total cholesterol,
LDL-C, and fasting insulin (P=0.004, P=0.01, and P=0.01,
Table 5. WMDs in Absolute and Relative Cardiorespiratory Fitness Comparing Exercise Intervention Groups to Control Groups by
Speciﬁc Modiﬁers
Modiﬁer
Absolute CRF (L/min) Relative CRF (mL/kg per minute)
n WMD 95% CI I2, % Pinteraction* n WMD 95% CI I
2, % Pinteraction
Age, y
<50 16 0.47 0.34 to 0.60 93.4 0.008 28 5.60 4.56 to 6.65 85.1 0.003
≥50 12 0.21 0.11 to 0.32 84.0 30 3.31 2.46 to 4.15 91.0
Sex
Women 25 0.19 0.13 to 0.24 92.3 <0.001 48 3.24 2.61 to 3.87 88.7 0.001
Men 27 0.42 0.32 to 0.53 90.4 37 5.43 4.32 to 6.53 90.2
Lifestyle
Active 9 0.33 0.15 to 0.51 97.0 0.89 14 3.62 1.39 to 5.85 96.5 0.83
Sedentary 43 0.31 0.25 to 0.37 88.4 88 3.85 3.36 to 4.33 90.5
BMI†
Obese 19 0.28 0.20 to 0.36 93.3 0.65 19 3.85 2.83 to 4.87 94.9 0.96
Nonobese 20 0.26 0.17 to 0.36 89.1 46 4.01 3.22 to 4.79 85.7
Health status‡
Yes 8 0.33 0.07 to 0.60 88.2 0.84 16 3.34 2.63 to 4.04 74.8 0.46
None 53 0.27 0.22 to 0.33 94.6 94 4.10 3.51 to 4.71 92.7
Duration, wk
<16 39 0.33 0.25 to 0.40 91.3 0.09 69 3.83 3.12 to 4.54 90.7 0.72
≥16 28 0.21 0.15 to 0.28 92.3 54 3.90 3.34 to 4.35 90.4
BMI indicates body mass index; CRF, cardiorespiratory ﬁtness; WMDs, weighted mean differences,
*P values for the impact of potential modiﬁers on the exercise effects.
†BMI in kg/m2: obese ≥30; nonobese <30.
‡Health status: participants having at least 1 of type 2 diabetes, hypertension, hyperlipidemia, or metabolic syndrome (yes) vs those with none of them (none).
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respectively) in people having at least 1 of type 2 diabetes,
hypertension, hyperlipidemia, and metabolic syndrome
(Tables 6 and 7, Figure 3); no such improvements were
observed among people without any of those health
conditions (P=0.44, P=0.19, and P=0.13, respectively)
(Tables 6 and 7, Figure 3).
Sensitivity Analyses
In light of the potential impact of exercise intensity, we
conducted separate analyses of all eligible comparisons for
moderate and vigorous exercise interventions, respectively.
The 95% CIs for moderate and vigorous interventions over-
lapped for both CRF measures and for all biomarkers (Table 8).
Discussion
This systematic review and meta-analysis of 160 RCTs
involving 7487 participants indicates that exercise training
may signiﬁcantly improve CRF and CVD biomarkers of lipid
and lipoprotein metabolism, glucose intolerance and insulin
resistance, systemic inﬂammation, and hemostasis (Figure 4).
In addition, we identiﬁed several important modiﬁers, includ-
ing age, sex, and health status, that may partially modify the
exercise effects on cardiovascular health.
The current meta-analysis shows that exercise, with
relatively low risk of side effects compared with medications,
may be an effective way to prevent CVD through impact on
various biomarkers. Our results from the meta-analysis
showed that exercise training signiﬁcantly raised CRF, which
has been demonstrated to be an independent predictor of
CVD risk, CVD mortality, and total mortality.200,201 Lower
levels of triglycerides and higher levels of HDL-C were
observed in exercise groups. Aside from conventional CVD
biomarkers, our meta-analysis also examined the effects on
biomarkers that have not been well studied in previous
studies, including biomarkers of insulin resistance and
hemostasis, adipokines, and novel lipid and inﬂammatory
biomarkers. We found evidence supporting the favorable
effects of exercise on apolipoprotein A1, interleukin-18,
fasting insulin, HOMA-IR, and hemoglobin A1c. Although the
exact biological mechanisms are not clear, our ﬁndings
indicate that exercise may exert cardioprotective effects by
altering dyslipidemia, inﬂammation, insulin resistance, and
hemostasis.19
As a major component of HDL, apolipoprotein A1 plays an
important role in the cardioprotective effects of HDL-C.202–204
Our ﬁndings on apolipoprotein A1 strengthen the hypothesis
that exercise may accelerate reverse cholesterol transport.
Another plausible mechanism by which exercise improves the
lipid proﬁle is by regulation of lipoprotein lipase. Various
studies have suggested that exercise may decrease the levels
of triglycerides and increase the levels of HDL-C through its
impact on lipoprotein lipase expression and activity, which
were consistent with the results from our meta-analysis.205–207
In addition, our analysis also conﬁrmed that the proportion of
CVD risk that could have been reduced by exercise via effects
on total cholesterol and LDL-C is much lower than what has
been observed previously.208,209 Consequently, the results
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Figure 3. Forest plot of effects of exercise interventions on cardiorespiratory ﬁtness, TC, TG, HDL-C, LDL-C, Fasting glucose, and fasting
insulin within subgroups. The WMDs (diamonds) and corresponding CIs (extended line) between exercise groups and control groups are shown
for each subgroup. Abs. CRF indicates absolute cardiorespiratory ﬁtness; BMI, body mass index; HDL-C, high-density lipoprotein cholesterol;
LDL-C, low-density lipoprotein cholesterol; Rel. CRF, relative cardiorespiratory ﬁtness; TC, total cholesterol; TG, triglycerides; WMDs, weighted
mean differences.
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Table 6. WMDs in Lipid Biomarkers Comparing Exercise Intervention and Control Groups by Speciﬁc Modiﬁers
Modiﬁer
Total Cholesterol (mg/dL) Total Triglycerides (mg/dL)
n WMD 95% CI I2, % Pinteraction* n WMD 95% CI I
2, % Pinteraction
Age, y
<50 12 4.25 10.1 to 1.55 0.0 0.43 12 6.20 14.2 to 2.66 34.3 0.21
≥50 15 0.77 5.41 to 7.35 72.5 13 1.77 8.86 to 13.3 75.5
Sex
Women 28 1.16 5.41 to 7.73 91.6 0.61 27 1.77 9.74 to 5.31 76.1 0.25
Men 15 0.39 5.80 to 5.03 54.3 13 8.86 14.2 to 4.43 12.8
Lifestyle
Active 6 8.12 7.73 to 24.0 92.5 0.71 5 8.86 30.1 to 12.4 61.2 0.64
Sedentary 47 1.93 13.9 to 17.4 99.1 43 3.54 9.74 to 2.66 75.1
BMI†
Obese 16 12.8 22.4 to 47.6 99.7 0.20 19 7.97 14.2 to 1.77 53.0 0.70
Nonobese 29 1.55 7.73 to 4.25 83.6 28 5.31 14.2 to 4.43 80.7
Health status‡
Yes 10 11.2 19.3 to 3.48 75.2 0.04 9 9.74 26.6 to 6.20 63.9 0.48
None 47 1.55 5.41 to 2.32 81.6 44 4.43 11.5 to 2.66 75.2
Duration, wk
<16 39 3.87 15.5 to 22.8 82.9 0.34 35 6.20 13.3 to 0.89 71.1 0.76
≥16 29 3.09 7.73 to 1.55 99.2 31 5.31 11.5 to 1.77 72.7
Modiﬁer
HDL-C (mg/dL) LDL-C (mg/dL)
N WMD 95% CI I2, % Pinteraction* N WMD 95% CI I
2, % Pinteraction
Age, y
<50 16 4.25 2.32 to 6.19 73.9 0.94 9 3.87 10.8 to 3.09 49.3 0.38
≥50 15 3.87 0.77 to 6.96 84.5 14 0.39 5.03 to 6.19 73.0
Sex
Women 28 2.32 0.08 to 4.64 84.8 0.80 24 1.93 9.67 to 5.80 95.0 0.93
Men 19 2.71 0.39 to 5.03 92.5 13 2.32 8.89 to 4.25 79.7
Lifestyle
Active 5 4.25 0.39 to 8.51 86.9 0.52 2 8.12 10.4 to 27.1 54.9 0.21
Sedentary 52 2.32 0.77 to 3.87 18.6 45 3.87 8.12 to 0.39 88.3
BMI†
Obese 19 4.25 1.93 to 6.96 88.1 0.13 14 0.08 4.64 to 4.25 62.0 0.33
Nonobese 30 1.16 1.16 to 3.87 83.0 25 4.25 10.4 to 2.32 91.4
Health status‡
Yes 11 2.71 2.32 to 7.73 91.2 0.89 12 11.6 19.7 to 3.09 80.8 0.06
None 50 2.32 0.77 to 3.87 87.3 39 3.09 7.73 to 1.55 89.3
Duration, wk
<16 39 2.71 1.16 to 4.64 83.0 0.55 29 3.09 9.28 to 3.48 89.6 0.63
≥16 35 1.93 0.15 to 0.28 90.4 30 4.64 10.4 to 1.16 92.2
BMI indicates body mass index; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; WMDs, weighted mean differences.
*P values for the impact of potential modiﬁers on the exercise effects.
†BMI in kg/m2: obese ≥30; nonobese <30.
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of the notion that, in addition to modifying total cholesterol
and
LDL-C, exercise training may also affect cardiovascular health
through other pathways. We found that people in exercise
groups also had signiﬁcantly lower levels of IL-18 and several
biomarkers of insulin resistance and hemostatic factors,
indicating that exercise may exert its effects via pathways of
inﬂammation-characterized atherothrombosis and insulin
resistance. A recent review suggested that exercise training
may regulate white adipose tissue mass and the expression of
adipokines.210 Obesity has become widely regarded as a
chronic proinﬂammatory state, and substantial evidence indi-
cates that chronic inﬂammation in adipose tissues, especially in
white adipose tissue, could lead to insulin resistance.211,212
Consequently, it is biologically plausible that by reducing the
white adipose tissue mass and regulating the expression of
adipokines, exercise could mitigate the chronic inﬂammation in
adipose tissues, resulting in improved insulin sensitivity.
Nevertheless, the exact mechanism remains to be elucidated.
The results from the subgroup analyses also may have
important clinical implications. Consistent with previous
evidence,213 both moderate and vigorous exercise training
appeared to have favorable effects on cardiorespiratory
ﬁtness and cardiometabolic health. We found that the
differences in CVD risk between exercise groups and control
groups were not signiﬁcantly modiﬁed by lifestyle, body mass
index, or intervention duration. These ﬁndings suggest that
exercise interventions may have similar effects on cardiovas-
cular health in populations regardless of these factors.
Alternatively, the effectiveness of exercise training appeared
to be different across strata of age, sex, and health status.
The effects of exercise interventions on CRF measures were
modiﬁed by age, sex, and health status such that people aged
<50 years, men, and people with type 2 diabetes, hyperten-
sion, hyperlipidemia, or metabolic syndrome appeared to
beneﬁt more from exercise interventions. We also observed
signiﬁcant modiﬁcation of the effects on total cholesterol and
LDL-C by preexisting medical conditions (type 2 diabetes,
hypertension, hyperlipidemia, or metabolic syndromes), and
that may explain why we did not ﬁnd signiﬁcant effects of
exercise on total cholesterol and LDL-C. This ﬁnding also
suggests that exercise interventions may provide signiﬁcant
beneﬁts for people with those preexisting conditions by
lowering total cholesterol and LDL-C.
Table 7. WMDs in Biomarkers of Glucose Intolerance and Insulin Resistance Comparing Exercise Intervention Groups to Control
Groups by Speciﬁc Modiﬁers
Modiﬁer
Fasting Glucose (mmol/L) Fasting Insulin (lIU/mL)
n WMD 95% CI I2, % Pinteraction* n WMD 95% CI I
2, % Pinteraction
Age, y
<50 5 0.09 0.11 to 0.29 91.3 0.57 4 1.34 3.44 to 0.76 76.9 0.22
≥50 7 0.01 0.06 to 0.07 36.9 3 0.45 1.23 to 2.13 75.6
Sex
Women 16 0.06 0.19 to 0.08 91.4 0.93 9 0.27 1.12 to 0.57 68.7 0.04
Men 9 0.07 0.25 to 0.12 84.3 6 2.86 3.55 to 2.17 0.0
Lifestyle
Active 2 0.20 0.74 to 0.34 99.0 0.63 0 NA NA NA NA
Sedentary 29 0.06 0.16 to 0.03 80.2 17 0.94 1.75 to 0.13 78.5
BMI†
Obese 20 0.06 0.20 to 0.07 90.7 0.90 13 0.93 2.18 to 0.32 82.0 0.88
Nonobese 18 0.05 0.17 to 0.07 80.7 10 0.86 1.52 to 0.19 32.8
Health status‡
Yes 9 0.18 0.40 to 0.05 0.0 0.40 6 2.68 4.67 to 0.70 75.2 0.05
None 27 0.03 0.11 to 0.06 87.2 14 0.70 1.60 to 0.21 77.5
Duration, wk
<16 30 0.10 0.22 to 0.03 90.0 0.70 13 1.35 2.50 to 0.20 79.3 0.58
≥16 19 0.02 0.09 to 0.06 47.5 16 0.83 1.83 to 0.17 78.7
BMI indicates body mass index; NA, not available due to the lack of comparisons reported for active participants; WMDs, weighted mean differences.
*P-values for the impact of potential modiﬁers on the exercise effects.
†BMI in kg/m2: obese ≥30; nonobese <30.
‡Health status: participants having at least 1 of type 2 diabetes, hypertension, hyperlipidemia, or metabolic syndrome (yes) vs those with none of them (none).
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Strengths of this meta-analysis include the comprehensive
and systematic review of both conventional and novel CVD
biomarkers, detailed subgroup analyses for potential effect
modiﬁers that have not been conducted previously, assess-
ment of robustness with regard to exercise intensity, and
evaluation of the risk of different bias. The 2008 Physical
Table 8. WMDs in Cardiorespiratory Fitness and Circulating Concentrations of Biomarkers Comparing Moderate and Vigorous
Exercise Intervention Groups to Control Groups
Outcome
Moderate Vigorous
No.* WMD 95% CI No.* WMD 95% CI
Cardiorespiratory fitness
Absolute, L/min 39 0.22 0.16 to 0.29 33 0.31 0.22 to 0.40
Relative, mL/kg per minute 64 3.22 2.61 to 4.18 68 3.26 2.63 to 3.89
Lipids markers
TC, mg/dL 41 4.25 7.73 to 16.6 28 3.87 31.7 to 39.8
TG, mg/dL 37 5.31 12.4 to 1.77 32 5.31 11.5 to 0.09
HDL-C, mg/dL 44 1.16 0.39 to 2.71 33 2.71 0.39 to 5.03
HDL2-C, mg/dL 2 1.16 0.77 to 3.48 2 1.55 1.16 to 4.25
HDL3-C, mg/dL 1 1.16 5.80 to 3.87 2 0.04 1.55 to 1.55
LDL-C, mg/dL 35 3.09 8.12 to 2.32 26 4.64 12.0 to 2.32
VLDL-C, mg/dL 5 1.93 5.41 to 1.93 2 7.35 22.9 to 6.19
Apo AI, g/L 4 0.03 0.02 to 0.04 1 0.00 0.12 to 0.12
Apo AII, g/L 1 0.001 0.24 to 0.24 1 0.01 0.01 to 0.03
Apo B, g/L 3 0.01 0.01 to 0.03 2 0.02 0.21 to 0.18
FFA, mmol/L 5 0.06 0.16 to 0.03 3 0.04 0.17 to 0.10
Inflammatory markers
CRP, mg/L 9 0.23 1.01 to 0.55 4 0.04 0.24 to 0.31
IL-6, pg/mL 5 0.02 0.22 to 0.25 2 0.39 0.83 to 0.06
IL-18, pg/mL 1 14.0 128 to 156 1 18.4 0.02 to 36.8
TNF-a, pg/mL 3 0.06 0.48 to 0.60 1 0.01 0.93 to 0.91
Adiponectin, lg/mL 1 3.52 1.17 to 5.87 6 0.52 0.20 to 1.23
Leptin, ng/mL 1 0.70 1.19 to 0.21 6 2.56 4.04 to 1.08
Insulin resistance markers
Glucose, mmol/L 31 0.04 0.24 to 0.17 22 0.03 0.08 to 0.12
Insulin, lIU/mL 17 0.91 2.08 to 0.26 17 1.32 2.15 to 0.50
HOMA-IR 7 0.30 0.66 to 0.06 7 0.47 0.82 to 0.12
HbA1c, % 11 0.28 0.46 to 0.11 7 2.71 0.54 to 0.002
C-peptide, nmol/L 1 0.22 0.19 to 0.25 1 0.18 0.62 to 0.26
IGF-1, ng/mL 2 4.64 29.58 to 20.30 3 3.91 2.87 to 10.69
IGF-BP3, lg/mL 0 NA NA 2 0.002 0.23 to 0.23
Hemostatic factors
Fibrinogen, g/L 0 NA NA 2 0.39 0.75 to 0.03
Endothelin-1, pg/mL 2 0.22 0.62 to 0.19 0 NA NA
Angiotensin II, pg/mL 2 1.32 2.11 to 0.54 0 NA NA
Apo AI indicates apolipoprotein A1; Apo AII, apolipoprotein A2; Apo B, apolipoprotein B; CRP, C-reactive protein; FFA, free fatty acid; HbA1c, glycosylated hemoglobin A1c; HDL-C, high-
density lipoprotein cholesterol; HOMA-IR, homeostatic model assessment–insulin resistance; IGF-1, insulin-like growth factor 1; IGF-BP3, insulin-like growth factor binding protein 3; IL,
interleukin; LDL-C, low-density lipoprotein cholesterol; NA, not available due to the lack of comparisons reported; TC, total cholesterol; TG, triglycerides; TNF-a, tumor necrosis factor a;
VLDL-C, very low-density lipoprotein cholesterol; WMDs, weighted mean differences.
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Activity Guidelines Advisory Committee Report included a
number of comprehensively systematic reviews and meta-
analyses based mostly on observational studies.214 The
evidence from RCTs has been relatively scarce, especially
for novel cardiometabolic biomarkers. Our study is the ﬁrst
that synthesized evidence from the RCT setting and covered a
comprehensive set of both traditional and novel biomarkers.
Our ﬁndings are corroborated by several previous meta-
analyses of RCTs,20,215 but the inclusion of both sexes, more
studies, subgroup analyses, and sensitivity analyses allowed
us to achieve higher precision in the estimates and to
determine the effect modiﬁcation in subgroups.
This meta-analysis had some limitations. First, the evi-
dence for hemostatic factors is based on a limited number of
available trials, and we were not able to synthesize evidence
for some novel biomarkers, such as plasminogen activator
inhibitor 1, lipoprotein(a), and homocysteine due to sparse
available data. Second, subgroup analyses were restricted to
outcomes with >20 studies included, and cutoff points used
for categorizing modiﬁers were arbitrarily selected. Third, due
to the heterogeneity of exercise training programs and the
limited number of RCTs that provided separate data, this
meta-analysis can neither perform a dose-response analysis
nor distinguish exercise types. We maximized the utility of
data regarding exercise duration and intensity available from
original RCTs and found that exercise effects were not
signiﬁcantly different across subgroups deﬁned by duration
and intensity. Our ﬁndings are consistent with previous
evidence showing that both moderate and vigorous exercise
training has similarly favorable effects on cardiometabolic
health.213 The duration threshold at which exercise exerts its
effects needs further investigation. Fourth, to maintain
independence, we selected 1 comparison from each trial
with exercise groups of different intensities compared with 1
single control group. The results may potentially be subject to
bias by excluding several eligible intervention groups with
moderate intensity; however, we found that the direction and
magnitude of the effects on most of the outcome measures
were quite similar between moderate and vigorous interven-
tions (Table 8). Finally, like any meta-analysis, our results may
be prone to publication bias and inherent weaknesses of
individual studies.
In conclusion, this large meta-analysis of RCTs clearly
shows that exercise training signiﬁcantly improved CRF and
some traditional and novel CVD biomarkers in adults without
CVD, indicating the causal role of exercise in the primary
prevention of CVD morbidity and mortality.
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